Batefenterol

Overview

Batefenterol (GSK961081;TD-5959) is a novel muscarinic receptor antagonist and β 2 -adrenoceptor agonist; displays high affinity for hM2, hM3 muscarinic and hβ 2 -adrenoceptor with K i values of 1.4, 1.3 and 3.7 nM, respectively.

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Adrenergic Receptor | Products > Signaling Pathways > mAChR

Product Information

• Catalog No.: HY-12980
• CAS No.: 743461-65-6
• Molecular Formula: C40H42ClN5O7
• Molecular Weight: 740.24
• Purity: 99.72%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (3.38 mM); Clear solution
• Availability: In-stock

Source

Original product source